Company: LIMN
Filing Date: 2025-07-28
Form Type: S-1/A
Source: 0001410578-25-001518
Chunk: 206

Company: Liminatus Pharma, Inc.
Filing Date: 2025-07-28
Form: S-1/A
Chunk 206
---
 Act of 1933, as amended, with respect to the shares of Common stock offered by this prospectus. This prospectus does not contain all of the information included in the registration statement. For further information pertaining to us and our securities, you should refer to the registration statement and our exhibits.

In addition, we file annual and current reports, and other information with the SEC. Our SEC filings are available to the public on a website maintained by the SEC located at www.sec.gov. Through our website, we make available, free of charge, annual and current reports, and other information as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. The information contained on, or that may be accessed through, our website is not part of, and is not incorporated into, this prospectus.

<div align='center'>132</div>

INDEX TO FINANCIAL STATEMENTS

| ​                                                                                                                                  | ​    |
| ​                                                                                                                                  | Page |
| Unaudited Financial Statements of Liminatus Pharma, Inc. (Successor to Iris Parent Holding Corp.)                                  | ​    |
| Condensed Consolidated Balance Sheets as of March 31, 2025 (unaudited) and December 31, 2024                                       | F-2  |
| Unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2025 and 2024                       | F-3  |
| Unaudited Condensed Consolidated Statements of Changes in Stockholder’s Deficit for the three months ended March 31, 2025 and 2024 | F-4  |
| Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2025 and 2024                       | F-5  |
| Notes to Unaudited Condensed Financial Statements                                                                                  | F-6  |

| ​                                                                                                          | ​    |
| Audited Financial Statements of Iris Parent Holding Corp.                                                  | ​    |
| Report of Independent Registered Public Accounting Firm                                                    | F-10 |
| Consolidated Balance Sheets as of December 31, 2024 and 2023                                               | F-11 |
| Consolidated Statements of Operations for the years ended December 31, 2024 and 2023                       | F-12 |
| Consolidated Statements of Changes in Stockholder’s Deficit for the years ended December 31, 2024 and 2023 | F-13 |
| Consolid